765 filings
Page 3 of 39
3
Bruce A. Sr. Cassidy
6 Oct 23
ORAGENICS / Bruce A. Sr. Cassidy ownership change
4:25pm
8-K
OGEN
Oragenics Inc
5 Oct 23
Departure of Directors or Certain Officers
5:29pm
8-K
OGEN
Oragenics Inc
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
OGEN
Oragenics Inc
29 Sep 23
Oragenics Enters into Agreement with Lantern Bioworks for Replacement-Therapy Assets
4:00pm
8-K
OGEN
Oragenics Inc
15 Sep 23
Termination of a Material Definitive Agreement
4:00pm
8-K
OGEN
Oragenics Inc
18 Aug 23
Changes in Registrant's Certifying Accountant
4:15pm
10-Q
2023 Q2
OGEN
Oragenics Inc
Quarterly report
11 Aug 23
4:16pm
4
Robert C Koski
10 Aug 23
ORAGENICS / ROBERT C KOSKI ownership change
4:30pm
4
OGEN
Oragenics Inc
10 Aug 23
ORAGENICS / CHARLES L POPE ownership change
4:30pm
4
Kimberly M Murphy
10 Aug 23
ORAGENICS / Kimberly M Murphy ownership change
4:30pm
4
Dunton Alan W
10 Aug 23
ORAGENICS / ALAN W DUNTON ownership change
4:30pm
4
Janet Huffman
10 Aug 23
ORAGENICS / Janet Huffman ownership change
4:30pm
4
Telling Fred
10 Aug 23
ORAGENICS / Fred Telling ownership change
4:30pm
8-K
OGEN
Oragenics Inc
10 Aug 23
Departure of Directors or Certain Officers
4:30pm
D
OGEN
Oragenics Inc
7 Aug 23
$850.00 k in equity, sold $850.00 k, 2 investors
6:37pm
8-K
OGEN
Oragenics Inc
7 Aug 23
Oragenics, Inc. Announces Private Placement
8:09am
8-K
OGEN
Oragenics Inc
5 Jun 23
Oragenics Project to Develop a Variant-Agnostic Protein Antigen for Use in its COVID-19 Intranasal Vaccine Receives Funding from CQDM
4:30pm
10-Q
2023 Q1
OGEN
Oragenics Inc
Quarterly report
12 May 23
4:51pm
10-K
2022 FY
OGEN
Oragenics Inc
Annual report
17 Apr 23
5:29pm
10-Q/A
2022 Q3
OGEN
Oragenics Inc
Quarterly report (amended)
14 Apr 23
4:08pm